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Amino acid metabolites in biofluids are associated with high body mass index (BMI) and 
cardiometabolic abnormalities. However, prospective investigations regarding these associations are 
few, particularly among young individuals. Moreover, little is presently known about the impact of 
long-term high BMI. Using data from the DOrtmund Nutritional and Anthropometric Longitudinally 
Designed study (111 males and 107 females), we prospectively investigated relations between 
repeatedly measured urinary levels of 33 metabolites and (1) previously identified long-term BMI 
trajectory groups from childhood into late adolescence and (2) cardiometabolic risk markers in late 
adolescence–young adulthood, in sex-specific linear mixed regression models. Males with long-term 
overweight had lower indole-3-acetic acid when compared to others. Further, methionine, isoleucine, 
tryptophan, xanthurenic acid, and indole-3-carboxaldehyde were negatively associated with C-reactive 
protein (CRP), but 5-hydroxyindole-3-acetic acid was positively associated with CRP. No associations 
were observed in females. Long-term overweight from childhood into late adolescence is associated 
with decreased urinary levels of gut bacteria-derived indole-3-acetic acid, and several urinary amino 
acids, including gut bacteria-derived indole-3-carboxaldehyde are associated with elevated CRP later on 
in life. taken together, our data suggest that indole metabolites, and their gut bacteria producers play 
potentially important roles in overweight-related inflammation.
High body mass index (BMI) during childhood and adolescence is still a major public health concern1,2. The 
condition contributes to the development of cardiometabolic abnormalities such as inflammation over the life 
course3. Dysregulated metabolism is one of the biological mechanisms through which high BMI contributes to 
the development of these cardiometabolic abnormalities4,5. Scientific efforts have focused on carbohydrate and 
lipid metabolic perturbations as one of these mechanisms, interest in the impact of unfavorable alterations in 
protein/amino acid metabolism is now emerging6,7. Therefore, it would be necessary to explore the link of high 
BMI, amino acid metabolites, and cardiometabolic abnormalities.
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Epidemiological studies in children and adolescents have reported positive association between BMI and 
biofluid amino acid and/or their metabolites such as alanine8,9, valine8–10, leucine8,10,11, isoleucine8,10,11, phenyla-
lanine8,11, tyrosine8,9,11, histidine8, cysteine12, tryptophan-derived metabolites13, kynurenic acid9,11, kynurenine11, 
the kynurenine to tryptophan ratio (KTR, an index of increased metabolism of tryptophan along the kynure-
nine pathway)14, lysine, methionine, γ-glutamyltyrosine, asparagine, glycine, serine11, and branched-chain amino 
acids15. Conversely, negative association between BMI and leucine, isoleucine, phenylalanine, arginine, histidine, 
serine, and citrulline4, glutamine9, indole-3-propionic acid16, and 5-hydroxyindole acetic acid17 are also docu-
mented. Some of these findings are restricted to males14,17. These BMI-related changes in amino acid profiles 
might be a consequence of higher or lower intake of specific protein-containing foods18, changes in the activities 
of catabolizing host and/or bacterial enzymes18,19, changes in the redox status of the adipose tissue and liver19, 
and down-regulation of the expression of adipose tissue amino acid metabolizing enzymes and uptake of amino 
acids by adipose tissue20.
Similarly, amino acid metabolites are positively related to cardiometabolic risk markers (CRM) in children, 
adolescents, and young adults, albeit with a few exceptions. The positive associations include branched-chain 
amino acids (BCAAs) with insulin resistance (IR)15,21,22, triglycerides23, and triglycerides to high-density 
lipoprotein-cholesterol (HDL-C) ratio24; valine, leucine, and isoleucine10, phenylalanine and tyrosine21, and 
kynurenine and KTR25 with IR; cysteine with fasting plasma glucose (FPG), leptin, and IR;12 indole-3 propi-
onic acid with HDL-C16; arginine, histidine, and serine with insulin sensitivity5; KTR with C-reactive protein 
(CRP), interferon-gamma, interleukin (IL)−6, IL-10, and alpha-1-acid glycoprotein26; and isoleucine and valine 
with IR27. The few reported negative associations include BCCAs with FPG23 and adiponectin24; tryptophan with 
CRP, interferon-gamma, IL-6, IL-10, and alpha-1-acid glycoprotein26; and numerous amino acids with CRP and 
IL-628. The relation of BCCA with BCCAs with FPG23 and adiponectin24, and that of isoleucine and valine with 
IR27 are restricted to males, while the relation of BCAA with triglycerides23, and triglycerides to HDL-C ratio24 
are restricted to females. The mechanistic involvement of BCCAs in the development of IR includes persistent 
activation of mTOR signaling pathway and accumulation of toxic BCAA metabolites that trigger mitochondrial 
dysfunction29, and the involvement of tryptophan and KTR in inflammation is through the immunoregulatory 
role of indoleamine 2,3-dioxygenase 130.
Notably, only a few of the aforementioned studies are prospective9,21,24–26. Thus, more prospective investiga-
tions are needed. Moreover, the one-time measurement of BMI in earlier studies indicate a relation between a 
static state of body composition and amino acid metabolites. Given that body composition is dynamic, particu-
larly among children and adolescents31, it would be necessary to investigate whether long-term BMI is associated 
with similar or different amino acid metabolites. Moreover, our knowledge of the relation between BMI and 
amino acid metabolites, and between amino acid metabolites and CRM might be incomplete because earlier 
studies sampled amino acids only at one time point. Static sampling of amino acids does not adequately capture 
the complex interplay of the several phases of host metabolism19. Further, some findings being restricted to either 
males or females warrants sex-specific analysis. Surely, aberrant amino acid metabolites may reveal metabo-
lites and/or metabolic pathways perturbed as a result of a high BMI and identification of amino acids related 
to CRM may improve our understanding of the pathophysiological mechanisms underlying cardiometabolic 
abnormalities.
In a group of apparently healthy young individuals in whom BMI was measured annually over a 15-year 
period from childhood to late adolescence, we previously identified distinct long-term BMI trajectory groups32. 
In a subset of this study sample, we therefore sought in sex-specific analysis to (1) examine association between 
long-term BMI trajectory groups and repeatedly measured urine metabolites, mostly amino acids, during child-
hood and adolescence, and (2) investigate whether these metabolites are prospectively associated with the levels 
of 11 CRM in late adolescence–young adulthood.
Results
Study population. Our study population comprised 111 males and 107 females. As published before32, 
overweight trajectory was present only in males, and more males followed the high-normal weight trajectory 
as compared to females. Urine was sampled in majority of individuals at ages 9, 17, 18. In late adolescence–
young adulthood, males had higher levels of SBP and FPG, while females had higher HDL-C, CRP, adiponectin, 
chemerin, and leptin. Males were heavier and longer than females at birth, males consumed more energy and 
protein daily as compared to females, and a lower percentage of mothers of males were employed as compared to 
mothers of females (Table 1).
Further details of the study participants’ age at urine sampling (metabolite measurement) are shown in Suppl. 
Table 1a,b. In both sexes, over half of the participants had their three measurements at ages 9, 17, and 18, and 
about 10% had measurements at ages 9, 16, and 17.
Multivariable linear regression. The association between BMI trajectory and metabolites. As shown in 
Suppl. Table 2, except for kynurenine and KTR in males, the linear time models yielded generally a better fit for 
the metabolites. Therefore, except for these two metabolites which we fitted with quadratic time models, all the 
remaining metabolites in both sexes were fitted with linear time models.
Table 2 shows the p-values and q-values of the association between BMI trajectory group and each of the 32 
metabolites and KTR in males and females. The results indicate that at p-value ≤ 0.05 and q-value ≤ 0.05, BMI 
trajectory group was significantly associated with 3-methoxy-p-tyramine (p-value = 0.005, q-value = 0.045), 
indole-3-acetamide (p-value = 0.005, q-value = 0.045), and indole-3-acetic acid (p-value = 0.0001, q-value = 
0.002) in males. However, BMI trajectory group was not associated with any metabolites in females. For this rea-
son, subsequent mean comparisons were performed for only 3-methoxy-p-tyramine, indole-3-acetamide, and 
indole-3-acetic acid in males.
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The results of the marginal mean difference in standard-deviation (SD) scores of 3-methoxy-p-tyramine, 
indole-3-acetamide, and indole-3-acetic acid between the BMI trajectory groups in males are shown in 
Fig. 1. Adjusting for time (model 1), the overweight and high-normal weight trajectory groups had lower 
3-methoxy-p-tyramine as compared to the mid-normal weight trajectory group. The overweight trajectory 
had lower indole-3-acetamide and indole-3-acetic acid as compared to all remaining three trajectory groups. 
Additionally, the high-normal weight trajectory group had lower indole-3-acetic acid as compared to the 
mid-normal weight trajectory group (Fig. 1, left). After full covariate adjustment (model 2), the overweight tra-
jectory had 0.54 SD, 0.83 SD, 0.67 SD lower indole-3-acetic acid as compared to the high-normal weight (−0.54: 
−1.04; −0.033, adjusted p-value =  0.033), mid-normal weight (−0.83: −1.33; −0.32, adjusted p-value =   < 0.001), 
and low-normal weight (−0.67: −1.22; −0.11, adjusted p-value =  0.012) trajectory groups, respectively (Fig. 1, 
right).
In humans, ultimate source of indole-3-acetic acid is tryptophan. Hence, in sensitivity analyses, BMI trajec-
tory group differences in indole-3-acetic acid were further adjusted for tryptophan. Adjusting for this precursor 
slightly attenuated the above result (Suppl. Table 3). This result was similar with further adjustment for urine 
creatinine or osmolality.
the association between metabolites and kynurenine and tryptophan ratio, and cardiomet-
abolic risk markers. Collectively, the metabolites and KTR explained between 26–54% and 10–89% of the 
variance in CRM in males and females, respectively (Table 3). However, at p-value ≤ 0.05 and q-value ≤ 0.05 
only the explained variance of CRP in males was statistically significant. The metabolites and KTR collectively 
explained 54% of the variance in CRP in males (p-value = 0.002, q-value = 0.025). Therefore for subsequent 
analysis, we reported associations between these metabolites and CRP in males.
n (males, females) Male Female p-value
BMI trajectory groupsa <0.001
Overweight 111, 107 16 (14)
High-normal weight 111, 107 40 (36) 30 (28)
Mid-normal weight 111, 107 33 (30) 40 (37)
Low-normal weight 111, 107 22 (20) 37 (35)
Urine sampling at ages 9, 17, and 18a 111, 107 57 (51) 64 (60) 0.201
Cardiometabolic risk markers in late adolescence–young adulthoodb
Systolic blood pressure, mmHg 111, 106 118 (110, 128) 110 (104, 118) <0.001
Diastolic blood pressure, mmHg 111, 106 72 (66, 78) 70 (64, 76) 0.101
Serum triglyceride, mg/dL 106, 102 79 (60, 112) 89 (68, 113) 0.746
Serum HDL-C, mg/dL 108, 103 49 (41, 58) 65 (55, 73) <0.001
Fasting plasma glucose, mg/dL 111, 105 95 (88, 100) 90 (86, 95) <0.001
C-reactive protein, mg/dL 111, 106 0.05 (0.03, 0.14) 0.12 (0.06, 0.26) <0.001
Interleukin-6, pg/mL 110, 106 0.7 (0.50, 1.04) 0.68 (0.48, 1.08) 0.827
Interleukin-18, pg/mL 109, 106 254.90 (210.51, 308.49) 247.92 (205.39, 306.55) 0.784
Adiponectin, ng/mL 110, 105 5910 (4389, 9241) 8758 (6512, 12976) <0.001
Chemerin, ng/mL 111, 106 140.86 (122.46, 162,52) 166.99 (149.66, 189.12) <0.001
Leptin, pg/mL 111, 102 2402 (1122, 5097) 12385 (8290, 19967) <0.001
Dietary intake and physical activity
Energy, kcal/dayb 108, 102 2483 (2232, 2805) 1836 (1642, 2034) <0.001
Protein, g/dayb 108, 102 84.62 (75.14, 94.40) 59.21 (53.21, 67.71) <0.001
Protein (%Energy)a 108, 102 13.52 (12.72, 14.57) 13.54 (12.20, 14.44) 0.347
Physical activity, metabolic equivalent 
task, hours/weekb 105, 99 53.82 (30.00, 68.65) 33.75 (17.95, 47.71) <0.001
Prenatal, birth, and early life
Birth weight, gb 111, 107 3580 (3210, 3850) 3380 (3100, 3680) <0.001
Birth length, cmb 111, 107 52 (51, 54) 51 (50, 53) <0.001
Maternal BMI, kg/m2b 109, 107 22.94 (21.11, 26.09) 22.47 (20.59, 25.47) 0.387
Maternal gestational weight gain, kgb 108, 106 12 (10, 15) 12.5 (10, 15) 0.362
Breastfeeding duration, weeksb 111, 107 23 (8, 35) 26 (7, 34) 0.943
First-born childa 111, 107 65 (59) 65 (61) 0.264
Maternal education, higha 79, 96 75 (95) 87 (91) 0.826
Maternal employment, employeda 78, 96 14 (13) 34 (32) <0.001
Smoking householda 82, 88 23 (28) 25 (28) 0.882
Table 1. Basic characteristics of the study population, 111 males and 107 females. an(%); bMedian (25th 
percentile, 75th percentile). n = count, % = percentage, BMI = Body mass index, HDL-C = High-density 
lipoprotein-cholesterol.
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As shown in the model comprising only the metabolites (model 1), methionine, isoleucine, picolinic 
acid, tryptophan, xanthurenic acid, and indole-3-carboxaldehyde were negatively associated with CRP, but 
5-hydroxyindole-3-acetic acid was positively associated with CRP (Fig. 2, left). Following full covariate adjust-
ment (model 2), a 1 SD increase in methionine (β = −0.70: −1.29; −0.12, p-value = 0.02), isoleucine (β = −2.03: 
−3.48; −0.59, p-value = 0.007), tryptophan (β = −2.74: −5.30; −0.17, p-value = 0.037), xanthurenic acid 
(β = 1 = −0.90: −1.62; −0.18, p-value = 0.015), and indole-3-carboxaldehyde (β = −0.53: −1.00; −0.06, 
p-value = 0.029) were associated with a 0.7 SD, 2 SD, 2.7 SD, 0.9 SD, and 0.5 SD decrease in CRP, respectively. 
Further, a 1 SD increase in 5-hydroxyindole-3-acetic acid (β = 1.26: 0.51; 2.01, p-value = 0.001) was associated 
with a 1.3 SD increase in CRP (Fig. 2, right). Indole-3-carboxaldehyde has the narrowest 95% CI, therefore its 
significant association with CRP has the least uncertainty. These results were essentially unaltered following addi-
tional adjustment for urine creatinine or osmolality.
Discussion
The aims of this study were to examine sex-specific associations between long-term BMI trajectory groups and repeat-
edly measured urine metabolites, mostly amino acids, among apparently healthy young individuals, and to investigate 
whether these metabolites are associated with the levels of subsequent CRM in late adolescence–young adulthood. 
We observed that individuals who belonged to the overweight trajectory group, that is, persistently overweight from 
childhood into late adolescent had lower levels of urinary indole-3-acetic acid when compared to other individuals. 
Furthermore, we found that methionine, isoleucine, tryptophan, xanthurenic acid, and indole-3-carboxaldehyde levels 
were independently negatively, and 5-hydroxyindole-3-acetic acid levels were independently positively associated with 
CRP in late adolescence–young adulthood. Interestingly, both findings were restricted to males.
Our sex-specific findings extends previous findings of studies in children and adolescents comprising both 
sexes. This includes a study reporting that high BMI was associated with a decreased KTR in males, but not 
MALES
GABA Met Val Leu Ile PA QA 5-HT DA
p-value 0.886 0.032 0.179 0.222 0.107 0.062 0.804 0.010 0.153
q-value
0.886 0.103 0.304 0.355 0.214 0.151 0.854 0.069 0.283
Tyr Phe Tyra 3-Me-Tyra HVA KA 5-OH-IAA Trp
p-value 0.466 0.524 0.036 0.005 0.072 0.026 0.042 0.252
q-value
0.566 0.614 0.103 0.045 0.163 0.103 0.110 0.372
Kyn XA IACT IAA ILA IPA IALD ICA
p-value 0.096 0.036 0.005 0.0001 0.025 0.031 0.833 0.343
q-value
0.204 0.103 0.045 0.002 0.103 0.103 0.859 0.485
AA 3-OH-AA Try 5-Me-IAA TrpME 5-OH-Trp 3-OH-kyn KTR
p-value 0.781 0.617 0.370 0.229 0.015 0.434 0.158 0.383
q-value 0.854 0.699 0.501 0.355 0.083 0.546 0.283 0.501
FEMALES
GABA Met Val Leu Ile PA QA 5-HT DA
p-value 0.439 0.812 0.485 0.131 0.258 0.843 0.940 0.888 0.966
q-value
0.755 0.966 0.755 0.755 0.755 0.966 0.966 0.966 0.966
Tyr Phe Tyra 3-Me-Tyra HVA KA 5-OH-IAA Trp
p-value 0.256 0.483 0.028 0.367 0.322 0.317 0.511 0.493
q-value
0.755 0.755 0.471 0.755 0.755 0.755 0.755 0.755
Kyn XA IACT IAA ILA IPA IALD ICA
p-value 0.787 0.964 0.024 0.158 0.949 0.885 0.480 0.121
q-value
0.966 0.966 0.471 0.755 0.966 0.966 0.755 0.755
AA 3-OH-AA Try 5-Me-IAA TrpME 5-OH-Trp 3-OH-kyn KTR
p-value 0.440 0.216 0.076 0.301 0.924 0.450 0.737 0.388
q-value 0.755 0.755 0.755 0.755 0.966 0.755 0.966 0.755
Table 2. The p-values and q-values of the association of body mass index trajectory group with 32 metabolites 
and kynurenine to tryptophan ratio in males and females. GABA = Gamma-aminobutyric acid; Met = 
Methionine; Val=Valine; Leu = Leucine; Ile=Isoleucine; PA = Picolinic acid; QA = Quinolinic acid; 
5-HT = Serotonin; DA = Dopamine; Tyr = Tyrosine; Phe=Phenylalanine; Tyra = Tyramine; 3-Me-Tyra = 
3-methoxy-p-tyramine; HVA = Homovanillic acid; KA = Kynurenic acid; 5-OH-IAA = 5-hydroxyindole-
3-acetic acid; Trp = Tryptophan; Kyn=Kynurenine; XA = Xanthurenic acid; IACT = Indole-3-acetamide; 
IAA = Indole-3-acetic acid; ILA = Indole-3-lactic acid; IPA = Indole-3-propionic acid; IALD = Indole-3-
carboxaldehyde; ICA = Indole-3-carboxylic acid; AA = Anthranilic acid; 3-OH-AA = 3-hydroxyanthranilic 
acid; Try = Tryptamine; 5-Me-IAA = 5-Methoxyindole-acetic acid; TrpME = Tryptophan methyl ester; 5-OH-
Trp = 5-hydroxy-tryptophan, 3-OH-Kyn = 3-hydroxykynurenine. KTR = Kynurenine to Tryptophan ratio The 
bolded metabolites indicate significant association with BMI trajectory at p-value ≤ 0.05 and q-value ≤ 0.05 
*Metabolites and time were normalized before statistical analyses.
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in females14. Moreover, BCCAs were associated with a decreased FPG in males, but increased triglycerides in 
females23 as well as with a decreased adiponectin in males, but with increased triglycerides to HDL-C ratio in 
females24. The fact these studies14,23,24 and ours consistently showed inverse associations in males suggest that 
our findings are unlikely to be spurious. Possible explanations for these observed sex-specific findings include 
sex-related differences in protein turnover, amino acid handling systems, and the influence of sex hormones33. 
Sex-related differences are thought to primarily develop after adolescence due to the more marked hormonal dif-
ferences33. However, considering that our study included measurement of metabolites in childhood, either indi-
cate that an impact of sex hormones occur before adolescence, or that all the aforementioned mechanisms provide 
a complete explanation of the sex-specific findings. These sex-specific findings warrant further investigation.
Overweight, either cross-sectionally or prospectively has not been previously linked to indole-3-acetic acid 
in children and adolescents. The few cross-sectional studies in adults regarding indole-3-acetic acid have yielded 
mixed results34–37. In agreement with our study, Liu et al. observed that BMI negatively correlated with sputum 
indole-3-acetic acid35, a result at variance with others in which no relation was observed between BMI and serum 
indole-3-acetic acid34, between BMI and faecal indole-3-acetic acid36, and between BMI and plasma indole-3-acetic 
acid in older men37. Clearly, BMI trajectory group differences being observed for only indolic tryptophan metab-
olite indicate that the impact of long-term BMI is very specific and does not result in a global disruption of all 
amino acid metabolism. However, our study failed to demonstrate an association with indole-3-propionic acid, 
an indole metabolite that has been cross-sectionally related to BMI in children and adolescents16. Indeed, the con-
sistent inverse relation of BMI with the indole metabolites in our study and Farook et al.16 suggest that high BMI 
impact indolic tryptophan metabolism, with the resulting metabolites being dependent on the duration of high BMI. 
Figure 1. Mean difference in standard-deviation scores of 3-methoxy-p-tyramine, indole-3-acetamide, and 
indole-3-acetic acid between pairs of body mass index trajectory groups in males. Model 1: left, Model 2: 
right. Model 1: adjusted for time. Model 2: adjusted for time, birth weight and length, maternal BMI, maternal 
pregnancy weight gain, breastfeeding duration, birth order, maternal education, and maternal employment, 
smoking in household, physical activity, daily energy intake, percentage of energy from protein, and two-way 




p-value q-value R-square values p-value q-value R-square values
Systolic blood pressure 0.811 0.893 0.28 0.716 0.868 0.71
Diastolic blood pressure, 0.017 0.095 0.49 0.218 0.560 0.22
Serum triglyceride 0.298 0.468 0.37 0.314 0.576 0.31
Serum high-density lipoprotein-cholesterol 0.122 0.384 0.41 0.891 0.891 0.89
Fasting plasma glucose 0.230 0.422 0.39 0.244 0.560 0.24
C-reactive protein 0.002 0.025 0.54 0.485 0.761 0.48
Interleukin-6 0.448 0.616 0.35 0.149 0.560 0.15
Interleukin-18 0.175 0.384 0.40 0.567 0.779 0.57
Adiponectin 0.164 0.384 0.41 0.789 0.868 0.79
Chemerin 0.676 0.8268 0.31 0.096 0.560 0.10
Leptin 0.898 0.898 0.26 0.254 0.560 0.25
Table 3. Overall significance of regression model with cardiometabolic risk markers as dependent variable and 
32 metabolites and kynurenine and tryptophan ratio as independent variables. The bolded cardiometabolic risk 
marker indicate a significant model at p-value ≤ 0.05 and q-value ≤ 0.05 *Metabolites and cardiometabolic risk 
markers were normalized before statistical analysis.
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Indole-3-acetic acid have been shown to drive the emergence of obesity by acting on the extended reward network36, 
however the current study modeled the effect of BMI trajectory group since it makes intuitive sense that changes 
in BMI impacted the levels of indole-3-acetic acid and our BMI measurements precedes metabolite measurements. 
Nonetheless, one cannot exclude the presence of a bidirectional association between BMI and indole-3-acetic.
In humans, indole-3-acetic acid is a tryptophan metabolite that are largely generated by the direct or indi-
rect metabolism of the gut microbiota38,39. Approximately 4–6% of tryptophan undergoes bacterial degradation 
to yield indole metabolites40. Since human de novo production of indole metabolites is unlikely40, the levels of 
indole-3-acetic acid is either a reflection of dietary intake (in this case, tryptophan-containing foods and cru-
ciferous vegetables) that are modulated by the gut bacteria or entirely a reflection of changes in gut microbial 
metabolism. There is a correlation between vegetable intake and calorie intake41, therefore controlling for calorie 
intake and protein intake, and their interaction with BMI trajectory group minimizes the influence of differential 
consumption of cruciferous vegetables and tryptophan-containing foods on our findings. The fact that trypto-
phan only minimally attenuate BMI trajectory group differences in indole-3-acetic acid also suggests that this 
association is independent of this precursor.
Clostridium bartlettii, several Bacteroides species and other bacteria have been reported to produce indole-
3-acetic acid42. This suggests that in individuals with long-term overweight, dysbiosis and/or altered metabolic 
functions of the gut microbiota results in decreased synthesis or increased utilization of indole-3-acetic acid. 
Although the potential of the gut bacteria of healthy humans to produce indole is very heterogeneous;43 the 
absence44 and lower levels45 of indoles in serum of germ-free animals compared to their conventionally raised 
counterparts suggest that these bacteria will be either absent or decreased in overweight individuals. Prospectively 
linking long-term overweight status with the abundance and function of the gut microbiota would help identify 
the altered bacteria, and linking the identified bacteria to levels of indole-3-acetic acid would help identify its 
producer in our study population. There are other gut microbiota-controlled tryptophan pathways46. Therefore, 
whether and the extent to which long-term overweight affects these pathways should be evaluated in future stud-
ies. Ultimately, indole-3-acetic acid may help to further characterize young individuals with different long-term 
BMI phenotypes. Overall, indolic tryptophan metabolic pathway seems to be highly dysregulated by long-term 
overweight.
Secondly, we observed that the levels of methionine, isoleucine, tryptophan, xanthurenic acid, and 
indole-3-carboxaldehyde from childhood into late adolescent were inversely related to CRP levels in late 
adolescence–young adulthood, but the levels of 5-hydroxyindole-3-acetic acid was directly related to CRP–a 
well-established marker of inflammation. Interestingly, all these metabolites are independently related to CRP, 
indicating that their association is not confounded by their precursors. While there is some evidence that 
changes in amino acids occur in inflammatory states47, it is less clear if these changes are a cause or a conse-
quence of inflammation. Only a few prospective investigations in children and adolescent have implicated amino 
acid metabolites in cardiometabolic risks21,24–26, and of these studies only one reported relations with CRP26. In 
Figure 2. Association of 32 metabolites and kynurenine to tryptophan ratio with CRP in males. Model 1: left, 
Model 2: right. Model 1 comprises all 32 metabolites and kynurenine and tryptophan ratio. Model 2 was Model 
1 adjusted for birth weight and length, maternal BMI, maternal pregnancy weight gain, breastfeeding duration, 
birth order, maternal education, and maternal employment, smoking in household, physical activity, daily 
energy intake, percentage of energy from protein, and BMI trajectory. *Multivariable adjusted p-value.
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agreement with our results, Kosek et al.26 found an inverse association between tryptophan and CRP. Similarly, a 
cross-sectional investigation, including children and adolescents, is in line with our findings of the inverse rela-
tion of methionine and tryptophan with CRP28.
To our knowledge, no previous study in childhood, adolescents, or young adults have prospectively linked 
methionine, isoleucine, xanthurenic acid, indole-3-carboxaldehyde, and 5-hydroxyindole-3-acetic acid to 
CRP. Nevertheless, cross-sectional investigations in older adults are in line with our findings. These include 
an inverse association of tryptophan48 and xanthurenic acid with CRP49, and a direct association between 
5-hydroxyindole-3-acetic acid and CRP50. Other studies in adults that contrast our findings include lack of 
association of isoleucine35, lack of association of methionine and tryptophan50, and positive relation of iso-
leucine51,52 with CRP. Although no study have reported an association between indole-3-carboxaldehyde and 
CRP; exogenous administration of indole-3-carboxaldehyde decreased the production of several inflammatory 
cytokines53. Consistent with our findings of several amino acids being related to CRP, a review concluded that 
several amino acids are involved in the development of future cardiometabolic abnormalities such as IR54. Since.
we adjusted for the precursors (tryptophan and serotonin) of indole-3-carboxaldehyde, xanthurenic acid, and 
5-hydroxyindole-3-acetic acid, it is unlikely that their association with CRP is due levels of these precursors or 
intake of diets rich in them. Systemic inflammation drives amino acid metabolism46; however our longitudinal 
study provides a direct evidence that variation in amino acid metabolites predates systemic inflammation.
The inflammatory role of the CRP-related amino acid metabolites in the current study have been docu-
mented. Methionine, an aliphatic, sulfur-containing, essential amino acid exerts anti-inflammatory activity 
through the activation of endogenous antioxidant enzymes such as methionine sulfoxide reductase A, and by 
counteracting oxidative stress through the biosynthesis of glutathione55. Isoleucine, a branched chain amino 
acid exerts anti-inflammatory activity through interference with the action and/or synthesis of prostaglandins56, 
and inducing the expression of β-defensins via G-protein-coupling receptors and ERK/MAPK signaling path-
ways57. Tryptophan, an essential aromatic amino acid, plays a critical role in controlling systemic inflammatory 
responses through its endothelium-derived metabolite 5-methoxytryptophan58. Xanthurenic acid is one of the 
several metabolites in the kynurenine pathway of tryptophan metabolism59. It reduces interferon-gamma pro-
duction60 and possesses powerful antioxidant properties61. Indole-3-carboxaldehyde (indole-3-aldehyde), a gut 
microbiota-derived indole derivative of tryptophan catabolism produced by the action of Lactobacillus-encoded 
tryptophanase inhibits inflammation through activation of the aryl hydrocarbon receptor in lymphoid cells62. 
Finally, 5-hydroxyindole-3-acetic acid is the most abundant end product of both central and peripheral enzymatic 
degradation of serotonin63. Although the direct biological activity of 5-hydroxyindole-3-acetic acid is yet to be 
documented; its excessive production by endocrine and neuroendocrine tumors63 and the large quantities of 
reactive oxygen species that are produced during its biosynthesis from serotonin64 might explain its association 
with systemic inflammation. Epidemiological studies have reported associations between proinflammatory state 
among adolescents and young adults and an increased risk of future cardiovascular diseases65, thus the amino 
acids associated with elevated CRP in the present study could be biomarkers of proinflammatory phase leading to 
the development cardiovascular diseases.
One major strength of this work is that it is a prospective study in apparently healthy young individuals. This 
prospective investigation indicates that the obtained exposure-outcome associations are reliable. Moreover, the 
repeated measurement of metabolites ensures that the metabolite levels of our participants are well captured, 
thereby providing greater confidence in our findings. In addition, for both research aims, we adjusted for pro-
tein and calorie intake since the metabolic fate of amino acids is dependent on their dietary availability. We also 
corrected for variations in physical activity and several early life factors. Only a few previous studies adequately 
controlled for these covariates. Finally, metabolites were profiled in urine which is a non-invasive biosample. 
Considering that the concentrations of several urine and plasma amino acids are correlated66, urine may be a 
substitute for plasma in profiling amino acids, especially in large epidemiological studies.
Notwithstanding the strengths of our study, one limitation is that this study is observational, so it cannot con-
firm causal relationships. It would be necessary to determine whether a causal relation exists between long-term 
BMI trajectory groups and these metabolites, and between these metabolites and CRP, and if it exists the magni-
tude of their causal relations. One approach that may improve causal inference of association of these metabolites 
with CRP within an observational study setting is by examining whether genetically determined levels of these 
metabolites are related to CRP in Mendelian randomization analysis. Secondly, the homogeneous nature of our 
study population, in terms of geographical location and socioeconomic background, may limit generalizability 
of our findings. These findings should be externally validated on more geographically, socioeconomically, and 
ethnically diverse populations. Besides, residual and unmeasured confounders such as medications might have 
influenced our results. Additionally, single imputation of covariates may have underestimated the uncertainty 
around the effect estimates in our adjusted models. Several host factors such as protein/amino acid absorption, 
catabolism and uptake, and excretion as well as kidney function might also confound our results. Future stud-
ies should consider the assessment of the aforementioned host factors such as measurement of faecal levels of 
these metabolites in order to rule out malabsorption. Moreover, our findings speculate about the role of the gut 
microbiota, without measuring the faecal levels of these metabolites. Faecal as well as circulating levels of these 
metabolites would have strengthened our findings.
In conclusion, this prospective investigation in apparently healthy young individuals shows that independent 
of several factors, males who were overweight from childhood into late adolescent have decreased urinary levels 
of gut bacteria-derived indole-3-acetic acid, and that several urinary amino acids, including gut bacteria-derived 
indole-3-carboxaldehyde, negatively predict serum CRP in late adolescence–young adulthood. Although exactly 
the same metabolite is not related to both long-term overweight and CRP, the fact that decreasing levels of indole 
metabolites-indole-3-acetic acid and indole-3-carboxaldehyde are associated with long-term overweight and ele-
vated CRP, respectively suggests that indole metabolites and their gut bacteria producers play an imperative role 
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in overweight-related inflammation among young individuals. These current findings further underline how the 
host phenotype and the microbiota interact to influence health outcomes. More human prospective studies and 
animal studies are needed to better understand the role of altered indolic tryptophan metabolism and the gut 
microbiota in overweight-associated systemic inflammation.
Subjects and Methods
Study design and participants. The study sample was selected from participants of the DOrtmund 
Nutritional and Anthropometric Longitudinally Designed (DONALD) study, an ongoing, open cohort study con-
ducted in Dortmund, Germany. This study collects data on diet, growth, development and metabolism of healthy 
children and adolescents since 1985. In the first few study years, approximately 300 participants >2 years old were 
also recruited. Since then, approximately 35–40 infants are newly recruited every year. The regular visits begin at 3 
months of age. The participants return for three more visits in the first year, two in the second year and thereafter 
annually until young adulthood. Yearly examinations include 3-day weighed dietary records, anthropometric 
measurements, collection of 24-h urine samples, interviews on lifestyle and medical examinations. Since 2005, 
participants >18 y are invited for subsequent examinations with fasting blood withdrawal. Parental examinations 
(anthropometric measurements, lifestyle interviews) take place every four years. Due to the specific design of the 
DONALD study, participants from well-educated mothers are overrepresented. Further details of the DONALD 
study were described elsewhere67. The study was approved by the Ethics Committee of the University of Bonn 
(approval number 098/06) and conducted according to the guidelines of the Declaration of Helsinki.
Statement attesting to informed consent for study participation. For all examinations in the 
DONALD study, written consent was obtained from parent and/or legal guardian of participants during their 
childhood phase and written consent was also obtained from study participants themselves later on in life. A 
statement attesting to informed consent from a parent and/or legal guardian for study participation was provide 
as thus, “I consent to my child being medically examined and physically measured by qualified personnel. I am 
prepared to answer questions about my child regarding pregnancy and birth, development and diseases, as well as 
lifestyle factors and diet, and to prepare dietary protocols. I agree to answer questions about my own health status 
and lifestyle and to have my height and weight measured”.
Study sample. The sample for the current analyses was a subset of 354 males and 335 females DONALD 
study participants from whom we previously identified long-term BMI trajectory groups from age four to 1832. 
These individuals are singletons, full term births (36 to 42 weeks), had a birth weight greater than or equal to 
2500 g, and had at least one BMI measurement in childhood (4–9.9 years), early adolescence (10–14.9 years), 
and late adolescence (15–18 years). Four trajectory groups (overweight, high-normal weight, mid-normal 
weight, and low-normal-weight), and three trajectory groups (high-normal weight, mid-normal weight, and 
low-normal-weight) were identified in males and females, respectively32. Of these individuals, 218 (111 males 
and 107 females) individuals provided 24-hour urine samples at three time-points over the course of BMI meas-
urement, and one blood sample in late adolescence–young adulthood (between age 18 and 39 years) (Fig. 3). The 
current analyses were based on data from these 111 males and 107 females.
Assessment of anthropometric variables, dietary intake and physical activity, early life and socio-economic 
characteristics
Anthropometric data for all participants were obtained by measurement that adhere to standard procedures 
during their annual study visit. BMI, standardized BMI z-scores, and their trajectories were determined, as pre-
viously reported32. Three-day weighed dietary records were used to collect nutritional data for three consecu-
tive days. Using all three-day dietary data, the nutrient intake was computed using the continuously updated 
in-house nutrient database, LEBTAB, and the individual mean daily intake of energy and protein over the three 
record days was calculated. Further, physical activity was assessed using a detailed questionnaire about the dura-
tion and frequency of both organized and non-organized physical activity. Physical activity was then expressed 
as daily energy expenditure in metabolic equivalent task-hours. Parents were interviewed about familial and 
socio-economic characteristics. Information on birth anthropometrics were extracted from a standardized docu-
ment (“Mutterpass”) given to all pregnant women in Germany. The BMI of the mother of the participants at study 
entry was also documented.
Urine sampling, preparation, and metabolic profiling of metabolites. Urine sampling. Annual 
24-h urine sampling were scheduled for participants older than 3 or 4 years. The sampling conducted at home 
follows a standardized procedure after detailed instruction to the families. Participants were asked to void their 
bladders upon getting up in the morning; this urine sample is completely discarded. This sets the start of the col-
lection and which ends with voiding the bladder in the next morning. The participants store the urine sample in 
preservative-free, Extran-cleaned (Extran, MA03; Merck, Darmstadt, Germany) 1 L plastic containers at less than 
−12 °C. The samples were transferred to the study centre where they were stored at −22 °C until analysis. Details 
of urine sampling have been presented elsewhere68.
Urine sample preparation and targeted metabolic profiling of metabolites. For each of the 
three 24-hour urine samples of the 111 males and 107 females in the current study, 25 µL aliquot and 225 µL 
of internal standard mix with water: acetonitrile 8:2 (v/v) were added (trypthophan-d5 at final concentration 
1 ppm; tyrosine-d4, methionine-d4, serotonin-d4, kynurenic acid-d5, 5-hydroxyindole-acetic acid- d5 and 
dopamine d5 at 0.5 ppm), were loaded in 96 well multifilter plates (Millipore). The target metabolites were 
detected and quantified on a UHPLC-ESI-Triple-quadrupole-MS (Waters®), using an injection volume of 
2 µL. Data processing was performed with Mass Lynx 4.1 software (Waters®). The 33 metabolites quantified 
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were gamma-aminobutyric acid, methionine, valine, leucine, isoleucine, picolinic acid, quinolinic acid, sero-
tonin, dopamine, tyrosine, phenylalanine, tyramine, 3-methoxy-p-tyramine, homovanillic acid, kynurenic 
acid, 5-hydroxyindole-3-acetic acid, tryptophan, kynurenine, xanthurenic acid, indole-3-acetamide, indole-
3-acetic acid, indole-3-lactic acid, indole-3-propionic acid, indole-3-carboxaldehyde, indole-3-carboxylic acid, 
anthranilic acid, 3-hydroxyanthranilic acid, tryptamine, 5-methoxyindole-acetic acid, tryptophan methyl ester, 
5-hydroxy-tryptophan, 3-hydroxykynurenine. The metabolites show a coefficient of variation lower than 1% and 
matrix effects, evaluated by the matrix match calibration approach, were minimal. Details of urine sample prepa-
ration and targeted metabolic profiling of amino acid metabolites can be found elsewhere69.
Blood sampling and measurement of cardiometabolic risk markers. In late adolescence–young 
adulthood, venous blood samples were drawn after an overnight fast, centrifuged within 15 min, and frozen 
at −80 °C. Circulating concentrations of HDL-C, FPG, CRP, IL-6, IL-18, adiponectin, chemerin, and leptin 
were measured. HDL-C was measured with the Advia 1650-Chemistry System analyser (Siemens Healthcare 
Diagnostics, Eschborn, Germany, FPG on a Roche/Hitachi Cobas c 311 analyzer (Basel, Switzerland), triglyc-
erides and CRP with the Roche/Hitachi Cobas c311 analyser (Roche diagnostics, Mannheim, Germany), IL-6 
with the Human IL-6 Quantikine HS ELISA (R&D Systems, Wiesbaden, Germany), IL-18 with the Human IL‐18 
ELISA (Medical and Biological Laboratories, Nagoya, Japan), adiponectin with the Human Total Adiponectin/
Acrp30 Quantikine ELISA kit (R&D Systems), chemerin with the Human Chemerin ELISA (BioVendor, Brno, 
Czech Republic), and leptin with Leptin Quantikine ELISA (R&D System) as previously described70,71.
Systolic (SBP) and diastolic blood pressures (DBP) were measured by the standard procedure at the study 
center, according to standardized procedures with an automated oscillometric device (Datascope Accutorr Plus, 
Mahwah, NJ, USA). For each participant, three consecutive BP measurements were taken at 3-min intervals 
after an initial 5-min rest and following a non-strenuous part of the examination. During the measurements, the 
participant’s back was supported in an upright position, with the right forearm resting on a table at heart level, 
and the legs uncrossed with feet on the floor. Therefore, in the present study, eleven CRM-SBP and DBP, serum 
triglycerides, HDL-C, FPG, CRP, IL-6, IL-18, adiponectin, chemerin, and leptin were analysed.
Statistical analyses. Participant characteristics. All statistical analyses were conducted using SAS 9.4 
(SAS®, SAS Institute, Cary, NC). Sex-specific baseline characteristics of the study sample (n = 218, males = 111, 
females = 107) are presented as medians and corresponding 25th and 75th percentiles or as counts (percentages) 
where appropriate. Sex-specific differences in baseline characteristics according to sex were explored using the 
Mann–Whitney U test and chi square tests for continuous and categorical data, respectively.
Multivariable linear regression. The association between BMI trajectory groups and metabolites. All 32 
metabolites and the KTR were normalized by calculating their rank normal scores using the Blom method. We 
used linear mixed models (PROC MIXED) to examine the association between BMI trajectory (categorical pre-
dictor variable) and each of the 33 (32 metabolites and KTR) dependent variables.
First, we determined the trends for each of the dependent variables over time (participants’ ages) by fitting 
unconditional linear and quadratic time models. We examined the convergence information and selected a better 
fitting model between the linear and quadratic time models as the one which minimizes the corrected Akaike’s 
Information Criterion. Time was expressed as a deviation from its mean in order to reduce multicollinearity 
between the linear and quadratic terms of the curvilinear model when the quadratic model indicated a better fit. 
The REPEATED statement was included in the PROC MIXED, and the individual was specified as the subject. 
Figure 3. An overview of the study and its research aims.
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The Kenward-Roger estimation method was used for calculating degrees of freedom. Due to the unequally spaced 
repeated measurements, we specified an exponential spatial covariance structure.
Then, we included the BMI trajectory group (categorical) variable as fixed effect and tested its association with 
each dependent variable. We obtained the overall significance (type 3 F-tests p-value) of the BMI trajectory and 
estimated its corresponding false discovery rate (FDR) p-value (q-value) by PROC MULTTEST. A combined 
p-value ≤ 0.05 and q-value ≤ 0.05 corrected with respect to the 33 dependent variables, were considered statis-
tically significant. Thus, model 1 includes BMI trajectory, time and BMI trajectory by time interaction (for linear 
model), with quadratic time, and BMI trajectory by quadratic time interaction (for curvilinear model).
When the BMI trajectory group effect was significant for a dependent variable in model 1, we further exam-
ined the heterogeneity across BMI trajectory groups as the marginal mean difference (and 95% Confidence inter-
val, CI) in the dependent variable using the LSMEANS statement. The confidence limits of the mean differences 
and p-value were adjusted for multiple comparisons with the simulate method. Model 1 was further adjusted for 
directed acyclic graph-identified minimal adjustment sets of covariates of the association between BMI trajectory 
and the dependent variables (model 2). These covariates were birth weight and length, maternal BMI, mater-
nal pregnancy weight gain, breastfeeding duration, birth order, maternal education, and maternal employment, 
smoking in household, physical activity, daily energy intake, percentage of energy from protein, and two-way 
interactions of physical activity, daily energy intake, and percentage of energy from protein with BMI trajectory.
Association between metabolites and cardiometabolic risk markers. To address the second aim, 
that is, whether metabolites are related to the 11 CRM (SBP, DBP, triglycerides, HDL-C, FPG, CRP, IL-6, IL-18, 
adiponectin, chemerin, and leptin), we constructed a two-stage model. In the first stage, we modeled the nor-
malized concentration of the 32 metabolites and KTR as a function of time using linear mixed models (PROC 
MIXED) with random coefficients and unstructured covariance-structure, and obtained individual-specific pre-
dicted value (best linear unbiased predictor, BLUP). In the second stage, in a multivariate multivariable linear 
model, the normalized CRM (dependent variables) were regressed on the BLUP estimates of the 33 independent 
variables (32 metabolites and KTR). We considered the CRM for which this model (model 1) showed significance 
at an overall F statistic p-value ≤ 0.05 and q-value ≤ 0.05. For significant model(s), metabolites were considered 
significant at p-value ≤ 0.05. In model 2, we adjusted for birth weight and length, maternal BMI, maternal preg-
nancy weight gain, breastfeeding duration, birth order, maternal education, and maternal employment, smoking 
in household, physical activity, daily energy intake, percentage of energy from protein, and BMI trajectory. The 
effect estimates and their 95% CIs represent the association between a 1-SD change in each metabolite and cor-
responding SD change in the CRM.
Handling of missing covariates. All covariates except birth weight and length, breastfeeding duration and 
birth order had missing values. The range of percentages of missing covariates were 2–30% in males and 1–18% in 
females. Using SAS function ‘proc mi’, we created a single imputed dataset in one burn in iterations with the fully 
conditional method, linear regression for continuous variables (maternal BMI, gestational weight gain), logistic 
regression for ordinal categorical variables (smoking household), and discriminant function for nominal categor-
ical variables (maternal education and maternal employment). Despite the single imputation’s limitation of not 
achieving uncertainty of missing data, we opted for this technique over the optimal multiple imputation because 
of the complexity of applying multiple imputation in longitudinal datasets72, the unstable results in longitudinal 
mixed-model analysis after multiple imputation73, and the generally low proportions of missingness in our data.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request and approval by the principal investigator.
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